<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07445161027146</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-355T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.528Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027153</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-370T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.492Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027160</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-395T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.468Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027177</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-425T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.444Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027184</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-455T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.419Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027191</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-485T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.400Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027207</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-530T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.376Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027214</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-565T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>07445161027221</udiDi>
    <basicUdiDi>7445161Ergo2DiamZenTempZS</basicUdiDi>
    <tradeName>Motiva Implants</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Establishment Labs</manufacturerName>
    <manufacturerSrn>CR-MF-000008155</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DSC-610T</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T17:07:51.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>B108784POEMTMEU00</udiDi>
    <basicUdiDi>++B108084POEUZ6</basicUdiDi>
    <tradeName>EMTONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BTL Industries Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000034894</manufacturerSrn>
    <authorisedRepresentativeName>BTL ITALIA S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000020508</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0599</emdnCode>
    <emdnDescription>HIGH INTENSITY ELECTROMAGNETIC RADIATION EMITTING EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED FOR USE ON THE HUMAN BODY, FOR SKIN RESURFACING, TATTOO OR HAIR REMOVAL OR OTHER SKIN TREATMENT – OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A784.201</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:51:24.978Z</lastUpdated>
  </row>
  <row>
    <udiDi>B108713POUNITMEU00</udiDi>
    <basicUdiDi>++B108713POUNITMEUET</basicUdiDi>
    <tradeName>BTL Vanquish ME</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BTL Industries Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000034894</manufacturerSrn>
    <authorisedRepresentativeName>BTL ITALIA S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000020508</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0402</emdnCode>
    <emdnDescription>EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE FOR LIPOLYSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A713.001</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:51:21.869Z</lastUpdated>
  </row>
  <row>
    <udiDi>B108713AP2MEU00</udiDi>
    <basicUdiDi>++B108713AP2MEUR7</basicUdiDi>
    <tradeName>713/2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BTL Industries Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000034894</manufacturerSrn>
    <authorisedRepresentativeName>BTL ITALIA S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000020508</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0402</emdnCode>
    <emdnDescription>EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE FOR LIPOLYSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A713.011</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:51:20.168Z</lastUpdated>
  </row>
  <row>
    <udiDi>B108713AP1MEU00</udiDi>
    <basicUdiDi>++B108713APEUWK</basicUdiDi>
    <tradeName>713/1</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BTL Industries Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000034894</manufacturerSrn>
    <authorisedRepresentativeName>BTL ITALIA S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000020508</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0402</emdnCode>
    <emdnDescription>EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE FOR LIPOLYSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>713-APPLICATOR</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:51:19.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>B108284AP01EMTMEU00</udiDi>
    <basicUdiDi>++B108284AP01EUMM</basicUdiDi>
    <tradeName>EMTONE Applicator BTL-284-01</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BTL Industries Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000034894</manufacturerSrn>
    <authorisedRepresentativeName>BTL ITALIA S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000020508</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0599</emdnCode>
    <emdnDescription>HIGH INTENSITY ELECTROMAGNETIC RADIATION EMITTING EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED FOR USE ON THE HUMAN BODY, FOR SKIN RESURFACING, TATTOO OR HAIR REMOVAL OR OTHER SKIN TREATMENT – OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A784.210</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:50:52.618Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF264GY</udiDi>
    <basicUdiDi>B-SPF264GY</basicUdiDi>
    <tradeName>D-SPF264GY</tradeName>
    <deviceName>DESIRIAL® PLUS</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF264</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:27.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF263GW</udiDi>
    <basicUdiDi>B-SPF263GW</basicUdiDi>
    <tradeName>D-SPF263GW</tradeName>
    <deviceName>DESIRIAL® PLUS</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF263</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:22.493Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF219GT</udiDi>
    <basicUdiDi>B-SPF219GT</basicUdiDi>
    <tradeName>D-SPF219GT</tradeName>
    <deviceName>STYLAGE® XL Lidocaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF219</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:08.592Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF218GR</udiDi>
    <basicUdiDi>B-SPF218GR</basicUdiDi>
    <tradeName>D-SPF218GR</tradeName>
    <deviceName>STYLAGE® L Lidocaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF218</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:04.587Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF217GP</udiDi>
    <basicUdiDi>B-SPF217GP</basicUdiDi>
    <tradeName>D-SPF217GP</tradeName>
    <deviceName>STYLAGE® M Lidocaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF217</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:03.779Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SPF216GM</udiDi>
    <basicUdiDi>B-SPF216GM</basicUdiDi>
    <tradeName>D-SPF216GM</tradeName>
    <deviceName>STYLAGE® S Lidocaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF216</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-15T04:00:02.977Z</lastUpdated>
  </row>
</eudamedExport>